Leidi.com Lei Jianping September 30
Beijing Tianzhu Changyun Medical Technology Co., Ltd. (referred to as "Tianzhu Changyun") recently passed its IPO and is preparing to be listed on the GEM of the Shenzhen Stock Exchange.
Tianzhu Changyun plans to raise 579 million yuan, of which 518 million yuan will be used for the Tianzhu Changyun (Wuxi) East China production and operation base project, and 61.067 million yuan will be used for the R&D center construction project.
Annual revenue 220 million
Tianzhu Changyun is mainly engaged in the research and development, production and sales of general surgical medical devices represented by hernia repair products. After more than 20 years of development, the company now has three categories of products: hernia repair products, absorbable anti-adhesion fibrous membranes and staplers.
The prospectus shows that Tianzhu Changyun's revenue in 2020, 2021 and 2022 will be 110 million yuan, 166 million yuan and 220 million yuan respectively; net profits will be 34.269 million yuan, 63.894 million yuan and 86 million yuan respectively; net profit after non-deductible They were 35.675 million yuan, 56.71 million yuan, and 76.01 million yuan respectively.
Tianzhu Changyun's revenue in the first quarter of 2023 was 49.01 million yuan, an increase of 2.53% from 47.8 million yuan in the same period last year; net profit was 16.9686 million yuan, an increase of 0.91% from 16.8156 million yuan in the same period last year; net profit after non-deduction was 15.89 million yuan, a decrease of 4.28% from 16.6 million yuan in the same period last year.
Liu Jian controls 49% of the shares
The controlling shareholder and actual controller of Tianzhu Changyun is Liu Jian. Liu Jian directly holds 27,525,000 shares of Tianzhu Changyun, accounting for 39.32% of the total share capital of Tianzhu Changyun. Changyun Tongying holds 7,000,000 shares, accounting for 10% of the total share capital of Tianzhu Changyun. Liu Jian is the executive partner of Changyun Tongying and has the right to represent Changyun Tongying externally and execute partnership affairs.
Accordingly, Liu Jian can control Changyun Tongying and then actually control the voting rights of 10% of the shares of Tianzhu Changyun held by Changyun Tongying. Liu Jian directly and indirectly controls 34,525,000 shares of Tianzhu Changyun, accounting for 49.32% of the total share capital of Tianzhu Changyun.
In addition, Ma Jin holds 22.01%, Meng Kai holds 13.97%, Kong Fanzhi holds 3.34%, Chen Guoqiang holds 2.93%, Huaxin holds 1.25%, Guo Wei holds 0.84%, and Deng Pinghua holds 0.84%. is 0.67%, Cao Kun holds 0.43%, and Gong Lijun holds 0.39%;
Zheng Zhiguo holds 0.34% of the shares, Chen Yanhua holds 0.28% of the shares, Ren Fulai and Liu Qi hold 0.21% of the shares respectively, and Tongchuang Sharing holds 3.33% of the shares.
After the IPO, Liu Jian directly held 29.49% of the shares, Ma Jin held 16.51%, Meng Kai held 10.48%, Kong Fanzhi held 2.51%, Chen Guoqiang held 2.19%, Huaxin held 0.94%, and Guo Wei holds 0.63% of the shares and Deng Pinghua holds 0.5%;
Cao Kun holds 0.32% of the shares, Gong Lijun holds 0.29% of the shares, Zheng Zhiguo holds 0.26% of the shares, Chen Yanhua holds 0.21% of the shares, Ren Fulai and Liu Qi hold 0.16% of the shares respectively, and Changyun Tongying holds 0.16% of the shares. 7.5%, and Tongchuang Sharing holds 2.5%.
———————————————
Leidi was founded by media person Lei Jianping. If you reprint, please indicate the source.
